With 6 million people enrolling in their benefits on a private health insurance, the market has seen annual growth in excess of 100% since 2013, and forecasts don't show the trend slowing, according Accenture.
With 6 million people enrolling in their benefits on a private health insurance, the market has seen annual growth in excess of 100% since 2013, and forecasts don’t show the trend slowing, according Accenture.
By 2018, 40 million enrollees will have gained insurance through a private exchange with the mid-size employer segment (100-2500 employees) driving the initial growth. Plus, 2 factors that were initially limiting growth of private health insurance exchange—capacity constraints and lagging adoption by large employers—are expected to no longer be an issue in the future.
With new entrants into the market, consolidation, investments, and organic growth, capacity constraints will erode over time. In addition, data from the initial wave of private exchange launches as well as actions being taken to address concerns, may be the proof needed by large employers to adopt a private insurance exchange.
“We remain optimistic that several factors will catalyze enrollment growth in private health insurance exchanges through 2018,” Rich Birhanzel, managing director for Accenture Health Administration Services, said in a statement. “This is especially true as the market matures, employers gain more control of benefit design, and evidence continues mounting on the tangible benefits of the model.”
In addition to the removal of some constraints that were slowing private health insurance exchange adoption, Accenture is seeing several accelerators, such as: the employer mandate; the Cadillac Tax, which places a 40% excise tax on high-cost plans; and increasing demand for more choice and flexibility.
Accenture also found that despite initial concerns, many employers did not drop coverage in 2015. The researchers reported that most employees view health insurance as a critical benefit provided by their employer with 76% of consumers saying health insurance is the primary or an important factor for continuing to work at their current employer. As a result, employers find it difficult to drop or defund health coverage, and as a result the private exchange model has become a favorite, according to the report.
“Employers’ drive to meet consumer expectations, spurred on by key accelerators, will lead to 40 million members on private exchanges by 2018,” Mr Birhanzel, Scott Brown, and Joshua Tauber wrote in the report.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More